These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9827256)

  • 81. [A multicenter epidemiological study of neonatal bacterial meningitis in parts of South China].
    Collaborative Study Group for Neonatal Bacterial Meningitis
    Zhonghua Er Ke Za Zhi; 2018 Jun; 56(6):421-428. PubMed ID: 29886604
    [No Abstract]   [Full Text] [Related]  

  • 82. Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.
    Nicasio AM; Quintiliani R; DeRyke CA; Kuti JL; Nicolau DP
    Ann Pharmacother; 2007 Jun; 41(6):1077-81. PubMed ID: 17472997
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Low Yield of Positive Cerebrospinal Fluid (CSF) Culture and Bacterial PCR Tests In Paediatric Patients With A Normal CSF White Cell Count.
    Drew RJ; Nielsen MJ; O'Mahony G; Cunney R
    Ir Med J; 2018 Feb; 111(2):693. PubMed ID: 29952442
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA.
    Craig WA
    Eur J Clin Microbiol Infect Dis; 1995 Jul; 14(7):636-42. PubMed ID: 7588857
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
    Di Paolo A; Gori G; Tascini C; Danesi R; Del Tacca M
    Clin Pharmacokinet; 2013 Jul; 52(7):511-42. PubMed ID: 23605634
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intrathecal Antibacterial and Antifungal Therapies.
    Nau R; Blei C; Eiffert H
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of antimicrobial pharmacokinetics and pharmacodynamics in surgical prophylaxis.
    Redington J; Ebert SC; Craig WA
    Rev Infect Dis; 1991; 13 Suppl 10():S790-9. PubMed ID: 1754787
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Principles in the treatment of bacterial meningitis.
    Täuber MG; Sande MA
    Am J Med; 1984 May; 76(5A):224-30. PubMed ID: 6372474
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Measurement of antimicrobial agents in cerebrospinal fluid using the Abbott TDx analyzer.
    Jandreski MA; Garbincius J
    J Clin Lab Anal; 1993; 7(5):263-8. PubMed ID: 8410486
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections.
    Mattie H
    Clin Investig; 1993 Jun; 71(6):480-2. PubMed ID: 8394759
    [No Abstract]   [Full Text] [Related]  

  • 92. Good abdominal drainage fluid penetration and pharmacokinetics analysis of vancomycin for severe acute pancreatitis: A case report.
    Wang C; Li X; Li C; He N; Ge Q; Zhai S
    J Clin Pharm Ther; 2021 Jun; 46(3):856-858. PubMed ID: 33393690
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.
    Kietzman C; Tuomanen E
    ACS Infect Dis; 2019 Dec; 5(12):1987-1995. PubMed ID: 31268283
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Detection of antibiotic contents in cerebrospinal fluid].
    Beloshitskiĭ GV; Koroleva IS
    Klin Lab Diagn; 2004 Aug; (8):44-6. PubMed ID: 15461004
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Antimicrobial penetration into cerebrospinal fluid.
    Richards ML; Prince RA; Kenaley KA; Johnson JA; LeFrock JL
    Drug Intell Clin Pharm; 1981 May; 15(5):341-68. PubMed ID: 7023900
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacokinetics of antibiotics in burn patients.
    Weinbren MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Central nervous system infections and antimicrobial resistance: an evolving challenge.
    Nau R; Sörgel F; Eiffert H
    Curr Opin Neurol; 2021 Jun; 34(3):456-467. PubMed ID: 33767092
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design.
    Ebert SC; Craig WA
    Infect Control Hosp Epidemiol; 1990 Jun; 11(6):319-26. PubMed ID: 2165081
    [No Abstract]   [Full Text] [Related]  

  • 99. In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells.
    Avedissian SN; Malik JR; Podany AT; Neely M; Rhodes NJ; Scarsi KK; Scheetz MH; Duryee MJ; Modebelu UO; Mykris TM; Winchester LC; Byrareddy SN; Fletcher CV
    Sci Rep; 2024 May; 14(1):10709. PubMed ID: 38729980
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comprehensive Therapeutic Approaches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies.
    Madadi AK; Sohn MJ
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.